News Archives - Page 399 of 737

MondayAug 09, 2021 11:10 am

Friendable Inc. (FDBL) Announces Successful Launch of Fan Pass Streaming Artist Platform’s Version 2.0

The updated Fan Pass platform features a slew of upgrades including an updated web design and an enhanced user interface/user experience The monthly subscription for fans to access the Fan Pass platform is less than a digital download, only $2.99 per month for an All-Access VIP experience The company plans to add NFTs to its offering and has a signed Letter of Intent with Santo Blockchain Labs and Santo Mining Corp. Fan Pass will continue to monetize livestream events, merchandise and fan subscribers — increasing revenue opportunities for the artists who sign up for the platform Mobile technology and entertainment…

MondayAug 09, 2021 11:03 am

TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Voted Best New Product at First B2B Convention

TAAT flagship product also earned distinction as second runner-up to Best in Show. “Awards are excellent indicator of how product is received by an audience of buyers keen to embrace concepts such as ours,” says CEO. Trade shows are key pieces in company’s strategic plan to grow presence, awareness in the tobacco industry. In its first convention appearance since launching in October of last year, TAAT(TM) Global Alternatives’ (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) flagship product was named Best New Product and earned the second-highest honor as Best in Show. The company began a round of trade shows by participating…

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

FridayAug 06, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Testing Volume Increase for First Half of 2021

Total number of paid tests and paid cancer tests increased significantly in Q2 over Q1 The company’s approach to multi-cancer screening is called Cancer Differentiation Analysis (“CDA”) that is powered by a database of over 200,000 samples and cases, changing the way to approach disease and cancer screenings The global cancer diagnostics market size is expected to reach $249.6 billion by 2026, growing at a CAGR of 7% during the forecast period AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company focused on early cancer screening, detection, and cancer treatment, announced that it experienced strong growth in test volume in the…

FridayAug 06, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Sees Important Trends in Sports Medicine and Plant-Therapy

As U.S. research restrictions are lifted there is a rising interest in the use of plant-therapy in sports medicine Cannabis in sports medicine took center stage at the Tokyo Olympics American athletes are turning more and more to cannabis as a pain reliever, alternative to opioids, and part of an overall sports recovery plan RYAH Group (CSE: RYAH) (formerly RYAH Medtech), the leader in dose-control technology for plant-based medicine, works with researchers to provide a full turnkey solution for clinical studies from start to finish. RYAH Group's dose-control devices standardize the dosing protocol, QR products ensure compliance, and mobile apps…

ThursdayAug 05, 2021 1:51 pm

reAlpha Is ‘One to Watch’

The company has the ability to rent out properties on Airbnb at scale reAlpha has raised more than $6 million in two funding rounds led by $1.3 billion real estate group Crawford Hoying As of July 2021, reAlpha is testing the waters on a Reg A public offering to raise $75 million The company plans to spend $1.5 billion to acquire short-term rental properties reAlpha’s use of technology and relationships with lending institutions allow it to analyze thousands of properties per minute and purchase hundreds of properties at a time reAlpha forecasts annual revenue of $434 million by 2025 The…

ThursdayAug 05, 2021 1:31 pm

FingerMotion Inc. (FNGR) Applies for NASDAQ Uplisting

FingerMotion recently announced it has submitted an application to be uplisted to NASDAQ The company believes listing its shares of common stock on the Nasdaq Capital Market, which is subject to approval and fulfillment of applicable requirements, will improve liquidity, increase its corporate visibility, and enhance shareholder value FingerMotion’s first upgrade came in February 2019, when it announced it had been uplisted and approved to trade on the OTCQB Venture Marketplace In January 2021, the company was again uplisted to the OTCQX, where it currently trades and will continue trading until its application to join the NASDAQ is approved FingerMotion…

ThursdayAug 05, 2021 1:22 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present Flagship PFN Program at 2021 Canaccord Genuity Virtual Growth Conference

The company will present an overview of business operations and its pipeline, including the Psilocybin-For-Neuropsychiatric Disorders (“PFN”) program for chronic pain and eating disorders The initial indication of lead drug candidate TRP-8802 is for fibromyalgia, but Tryp believes that psilocybin can be used for much more in the realm of unmet medical needs PFN’s development for its proprietary drug candidate, TRP-8803, focuses on increased efficacy, natural blood-brain barrier penetration, enhanced safety and toxicity profiles, reduced risk of abuse, and reduced risk of addiction Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a San Diego-based pharmaceuticals company, has joined the lineup of presenters…

ThursdayAug 05, 2021 1:15 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://ibn.fm/ofMBY). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

Site Search

Company Search

Category: News